ENTRADA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.76 USD | +2.89% |
|
+9.70% | -1.86% |
Chart calendar Entrada Therapeutics, Inc.
b636a6c4772b4459cca4.E8P8y3XNSkhRsYvS1Gy-dCpJC-UEHW6jSMUZaxCFIr0.QKe7n0eCfQ88w7jh51TKOBpwYbZCZF6aMbxfOXK0Y-5rsKj-LfQ9OQjZ0g~9c0440920efa7b50d28969bb3468e31f
Upcoming events on Entrada Therapeutics, Inc.
Past events on Entrada Therapeutics, Inc.
| 2024-05-09 12:00 am | Q1 2024 Earnings Release |
| 2024-03-13 07:00 am | Q4 2023 Earnings Release |
| 2024-03-04 09:10 am | TD Cowen Health Care Conference |
| 2024-02-14 02:00 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-29 03:50 pm | Evercore ISI HealthCONx Conference |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-10-16 11:00 am | William Blair Innovator Series Conference |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-07 09:30 am | Wells Fargo Healthcare Conference |
| 2023-08-08 07:00 am | Q2 2023 Earnings Release |
| 2023-06-14 01:40 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-08 09:30 am | Annual General Meeting |
| 2023-05-10 07:00 am | Q1 2023 Earnings Release |
| 2023-04-04 09:00 am | Guggenheim Genomic Medicines and Rare Disease Day |
| 2023-03-18 | Muscular Dystrophy Association Clinical & Scientific Conference |
| 2023-03-08 02:10 pm | Cowen Health Care Conference |
| 2023-03-06 07:00 am | Q4 2022 Earnings Release |
| 2022-11-29 03:55 pm | Evercore ISI HealthCONx Conference - Fireside Chat |
| 2022-11-07 07:00 am | Q3 2022 Earnings Release |
| 2022-09-07 07:00 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 129 111 16.36% | 143 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -50,0 -61,9 19.25% | -95,4 -96,3 0.96% | -0,32 -21,1 98.48% | -28,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -51,1 -59,1 13.52% | -97,2 -96,9 -0.37% | -3,16 -15,1 79.05% | -20,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,2 -55,2 7.32% | -94,6 -95,6 1.03% | 12,1 -0,83 1554.28% | -7,23 |
|
Net income Million USD | Released Forecast Spread | -26,5 | -51,2 -55,2 7.32% | -94,6 -95,6 1.03% | -6,69 -1,32 -405.39% | -17,7 |
|
EPS USD | Released Forecast Spread | -3,32 | -8,16 -6,25 -30.56% | -3,02 -3,07 1.47% | -0,20 -0,04 -370.59% | -0,48 |
| Announcement Date | 06/08/21 | 15/03/22 | 06/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 25,3 79,3 -68.16% | 18,2 9,78 85.86% | 43,7 9,60 355.69% | 41,8 23,7 76.61% | 59,1 15,2 289.09% | 36,1 | 24,5 | 22,1 | ||
|
EBIT Million USD | Released Forecast Spread | -22,2 -20,4 -8.67% | -23,6 -22,9 -3.05% | -25,9 -24,0 -7.86% | -25,6 -26,1 2.01% | -5,78 51,8 -111.16% | -16,3 -22,9 28.71% | 14,0 -26,1 153.73% | 4,91 -7,56 164.87% | 21,1 -16,6 226.97% | -3,21 | -17,4 | -20,4 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,7 -20,5 -5.71% | -23,2 -22,5 -3.02% | -25,1 -23,5 -6.97% | -24,6 -25,7 4.17% | -3,12 85,3 -103.66% | -12,1 -19,2 36.97% | 18,1 -23,2 177.87% | 9,20 -3,70 348.69% | 25,3 -17,2 247.25% | -14,0 | -17,8 | -22,5 | ||
|
Net income Million USD | Released Forecast Spread | -21,7 -20,5 -5.71% | -23,2 -22,5 -3.02% | -25,1 -23,5 -6.97% | -24,6 -25,7 4.17% | -6,67 85,3 -107.83% | -25,9 -19,8 -30.79% | 35,5 -23,9 248.65% | -9,54 -4,19 -127.67% | 23,5 -17,2 236.6% | -14,0 | -17,8 | -22,5 | ||
|
EPS USD | Released Forecast Spread | -0,69 -0,66 -4.55% | -0,74 -0,72 -2.78% | -0,80 -0,75 -6.67% | -0,78 -0,83 6.02% | -0,21 2,57 -108.19% | -0,78 -0,60 -29.28% | 1,02 -0,71 242.99% | -0,28 -0,12 -128.57% | 0,68 -0,56 221.43% | 0,14 | -0,52 | -0,55 | -0,97 | -1,01 |
| Announcement Date | 12/05/22 | 11/08/22 | 07/11/22 | 06/03/23 | 10/05/23 | 08/08/23 | 07/11/23 | 13/03/24 | 07/05/24 | - | - | - | - | - |
| 2024-05-13 | IMMATICS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 2024-05-13 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-14 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Past sector events for Entrada Therapeutics, Inc.
| Today | PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release |
| Today | ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release |
| Today | PEPTRON, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRDA Stock
- Calendar Entrada Therapeutics, Inc.